This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Frohlich, E. D. Search for Related Content PubMed PubMed Citation Articles by Frohlich, E. D.

(Hypertension. 2001;38:1480.)
© 2001 American Heart Association, Inc.

Hypertension Electronic Pages

Hypertension Online Only

December 2001

Edward D. Frohlich, Editor-in-Chief
The Scientific Publishing Committee has approved Hypertension to receive a limited number of electronic pages. These electronic pages will be used to help increase the number of referenceable pages for the journal by allowing us to publish Editorials, Letters to the Editors and their respective responses, Scientific Contributions, and other materials online. Thus, Hypertension Online material will be indexed in Index Medicus, MEDLINE, and PubMed. Each online item will also be featured in the Table of Contents on the cover, denoted by a green star, as well as in the Table of Contents within the journal, denoted by the letter e in front of the page number. Hypertension is available online at http://www.hypertensionaha.org

In Memoriam

(Hypertension. 2001;38:e27.)

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures
A HOPE Substudy
Per Svensson

Ulf de Faire

Peter Sleight

Salim Yusuf

Jan Östergren

Abstract—
In the HOPE-trial, the ACE inhibitor ramipril significantly reduced cardiovascular morbidity and mortality in patients at high risk for cardiovascular events. The benefit could only partly be attributed to the modest mean reduction of office blood pressure (OBP) during the study period (3/2 mm Hg). However, because according to the HOPE protocol ramipril was given once daily at bedtime and blood pressure was measured during the day, the 24-hour reduction of blood pressure may be underestimated based on OBP. Thirty-eight patients with peripheral arterial disease enrolled in the HOPE study underwent 24-hour ambulatory blood pressure (ABP) measurement before randomization and after 1 year. OBP was measured in the sitting position immediately before fitting the ABP measuring equipment to the patients. Ramipril did not significantly . . . [Full Text of this Article]